Case studies
Strategic Pipeline for RNA Regulation Therapies
Strategic evaluation and prioritization of diseases through epidemiological, mechanistic, and competitive analysis for splicing modulation therapies
Challenge
A novel RNA-regulation therapeutic approach required transforming its scientific potential into a prioritized development strategy. Arvor needed to evaluate thousands of rare diseases to identify those with the strongest epidemiological, mechanistic, and competitive fit, defining viable opportunities to build a robust and differentiated pipeline.
Solution
Arvor carried out a systematic process for selecting and validating therapeutic indications through the analysis of clinical databases, scientific literature, and competing pipelines. This work enabled the identification of diseases with strong biological coherence for RNA-based therapies and the development of a diversification strategy focused on opportunities with clinical and commercial potential.
Result
The project enabled the prioritization of a group of diseases with high potential for the development of splicing modulation therapies. As a result, the client now has a clear pipeline diversification strategy, objective prioritization criteria, and a strong narrative to support preclinical validation, investment discussions, and future strategic partnerships.
“As a result, the client now has a clear pipeline diversification strategy”
Success case studies in the sector Biotech
Case studies of Market analysis